1A8I | A:486-812; A:10-485,A:813-832 | SPIROHYDANTOIN INHIBITOR OF GLYCOGEN PHOSPHORYLASE |
1ABB | A:486-812; B:10-485,B:813-836; C:10-485,C:813-836; D:10-485,D:813-836; A:10-485,A:813-837; B:486-812; C:486-812; D:486-812 | CONTROL OF PHOSPHORYLASE B CONFORMATION BY A MODIFIED COFACTOR: CRYSTALLOGRAPHIC STUDIES ON R-STATE GLYCOGEN PHOSPHORYLASE RECONSTITUTED WITH PYRIDOXAL 5'-DIPHOSPHATE |
1AXR | A:486-812; A:14-485,A:813-836 | COOPERATIVITY BETWEEN HYDROGEN-BONDING AND CHARGE-DIPOLE INTERACTIONS IN THE INHIBITION OF BETA-GLYCOSIDASES BY AZOLOPYRIDINES: EVIDENCE FROM A STUDY WITH GLYCOGEN PHOSPHORYLASE B |
1B4D | A:486-812; A:13-485,A:813-833 | AMIDOCARBAMATE INHIBITOR OF GLYCOGEN PHOSPHORYLASE |
1BX3 | A:486-812; A:13-485,A:813-833 | EFFECTS OF COMMONLY USED CRYOPROTECTANTS ON GLYCOGEN PHOSPHORYLASE ACTIVITY AND STRUCTURE |
1C50 | A:486-812; A:13-485,A:813-836 | IDENTIFICATION AND STRUCTURAL CHARACTERIZATION OF A NOVEL ALLOSTERIC BINDING SITE OF GLYCOGEN PHOSPHORYLASE B |
1C8K | A:486-812; A:13-485,A:813-836 | FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE INHIBITOR SITE |
1C8L | A:486-812; A:10-485,A:813-832 | SYNERGISTIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL ANTIDIABETIC DRUG AND CAFFEINE |
1FS4 | A:486-812; A:13-485,A:813-836 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
1FTQ | A:486-812; A:13-485,A:813-836 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
1FTW | A:486-812; A:13-485,A:813-836 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
1FTY | A:486-812; A:13-485,A:813-836 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
1FU4 | A:486-812; A:13-485,A:813-836 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
1FU7 | A:486-812; A:13-485,A:813-836 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
1FU8 | A:486-812; A:13-485,A:813-836 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
1GFZ | A:486-812; A:13-485,A:813-835 | FLAVOPIRIDOL INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE INHIBITOR SITE |
1GG8 | A:486-812; A:13-485,A:813-836 | DESIGN OF INHIBITORS OF GLYCOGEN PHOSPHORYLASE: A STUDY OF ALPHA-AND BETA-C-GLUCOSIDES AND 1-THIO-BETA-D-GLUCOSE COMPOUNDS |
1GGN | A:486-812; A:13-485,A:813-836 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN |
1GPA | A:486-812; B:10-485,B:813-836; A:10-485,A:813-836; C:10-485,C:813-836; D:10-485,D:813-836; B:486-812; C:486-812; D:486-812 | STRUCTURAL MECHANISM FOR GLYCOGEN PHOSPHORYLASE CONTROL BY PHOSPHORYLATION AND AMP |
1GPB | A:486-812; A:19-485,A:813-836 | GLYCOGEN PHOSPHORYLASE B: DESCRIPTION OF THE PROTEIN STRUCTURE |
1GPY | A:486-812; A:14-485,A:813-836 | CRYSTALLOGRAPHIC BINDING STUDIES ON THE ALLOSTERIC INHIBITOR GLUCOSE-6-PHOSPHATE TO T STATE GLYCOGEN PHOSPHORYLASE B |
1H5U | A:486-812; A:13-485,A:813-835 | THE 1.76 A RESOLUTION CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B COMPLEXED WITH GLUCOSE AND CP320626, A POTENTIAL ANTIDIABETIC DRUG |
1HLF | A:486-812; A:13-485,A:813-836 | BINDING OF GLUCOPYRANOSYLIDENE-SPIRO-THIOHYDANTOIN TO GLYCOGEN PHOSPHORYLASE B: KINETIC AND CRYSTALLOGRAPHIC STUD |
1K06 | A:486-812; A:13-485,A:813-835 | CRYSTALLOGRAPHIC BINDING STUDY OF 100 MM N-BENZOYL-N'-BETA-D-GLUCOPYRANOSYL UREA TO GLYCOGEN PHOSPHORYLASE B |
1K08 | A:486-812; A:13-485,A:813-836 | CRYSTALLOGRAPHIC BINDING STUDY OF 10 MM N-BENZOYL-N'-BETA-D-GLUCOPYRANOSYL UREA TO GLYCOGEN PHOSPHORYLASE B |
1KTI | A:486-812; A:13-485,A:813-834 | BINDING OF 100 MM N-ACETYL-N'-BETA-D-GLUCOPYRANOSYL UREA TO GLYCOGEN PHOSPHORYLASE B: KINETIC AND CRYSTALLOGRAPHIC STUDIES |
1LWN | A:486-812; A:10-485,A:813-835 | CRYSTAL STRUCTURE OF RABBIT MUSCLE GLYCOGEN PHOSPHORYLASE A IN COMPLEX WITH A POTENTIAL HYPOGLYCAEMIC DRUG AT 2.0 A RESOLUTION |
1LWO | A:486-812; A:10-485,A:813-835 | CRYSTAL STRUCTURE OF RABBIT MUSCLE GLYCOGEN PHOSPHORYLASE A IN COMPLEX WITH A POTENTIAL HYPOGLYCAEMIC DRUG AT 2.0 A RESOLUTION |
1NOI | A:486-812; B:486-812; C:486-812; D:486-812; A:10-485,A:813-836; B:10-485,B:813-836; C:10-485,C:813-836; D:10-485,D:813-836 | COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T AND R STATES |
1NOJ | A:486-812; A:12-485,A:813-836 | COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T STATE |
1NOK | A:486-812; A:12-485,A:813-836 | COMPLEX OF GLYCOGEN PHOSPHORYLASE WITH A TRANSITION STATE ANALOGUE NOJIRIMYCIN TETRAZOLE AND PHOSPHATE IN THE T STATE |
1P29 | A:486-812; A:12-485,A:813-833 | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH MALTOPENTAOSE |
1P2B | A:486-812; A:12-485,A:813-833 | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH MALTOHEPTAOSE |
1P2D | A:486-812; A:12-485,A:813-834 | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH BETA CYCLODEXTRIN |
1P2G | A:486-812; A:12-485,A:813-833 | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH GAMMA CYCLODEXTRIN |
1P4G | A:486-812; A:12-485,A:813-835 | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH C-(1-AZIDO-ALPHA-D-GLUCOPYRANOSYL)FORMAMIDE |
1P4H | A:486-812; A:12-485,A:813-835 | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH C-(1-ACETAMIDO-ALPHA-D-GLUCOPYRANOSYL) FORMAMIDE |
1P4J | A:486-812; A:12-485,A:813-835 | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH C-(1-HYDROXY-BETA-D-GLUCOPYRANOSYL)FORMAMIDE |
1PYG | A:486-812; B:20-485,B:813-834; A:10-485,A:813-834; C:10-485,C:813-834; D:10-485,D:813-834; B:486-812; C:486-812; D:486-812 | STRUCTURAL BASIS FOR THE ACTIVATION OF GLYCOGEN PHOSPHORYLASE B BY ADENOSINE MONOPHOSPHATE |
1UZU | A:486-812; A:12-485,A:813-835 | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH INDIRUBIN-5'-SULPHONATE |
1WUT | A:486-812; A:13-485,A:813-833 | ACYL UREAS AS HUMAN LIVER GLYCOGEN PHOSPHORYLASE INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES |
1WUY | A:486-812; A:13-485,A:813-833 | CRYSTALLOGRAPHIC STUDIES ON ACYL UREAS, A NEW CLASS OF INHIBITORS OF GLYCOGEN PHOSPHORYLASE. BROAD SPECIFICITY OF THE ALLOSTERIC SITE |
1WV0 | A:486-812; A:13-485,A:813-833 | CRYSTALLOGRAPHIC STUDIES ON ACYL UREAS, A NEW CLASS OF INHIBITORS OF GLYCOGEN PHOSPHORYLASE. BROAD SPECIFICITY OF THE ALLOSTERIC SITE |
1WV1 | A:486-812; A:13-485,A:813-833 | CRYSTALLOGRAPHIC STUDIES ON ACYL UREAS, A NEW CLASS OF INHIBITORS OF GLYCOGENPHOSPHORYLASE. BROAD SPECIFICITY OF THE ALLOSTERIC SITE |
1WW2 | A:486-812; A:12-485,A:813-833 | CRYSTALLOGRAPHIC STUDIES ON TWO BIOISOSTERIC ANALOGUES, N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE AND N-TRIFLUOROACETYL-BETA-D-GLUCOPYRANOSYLAMINE, POTENT INHIBITORS OF MUSCLE GLYCOGEN PHOSPHORYLASE |
1WW3 | A:486-812; A:12-485,A:813-833 | CRYSTALLOGRAPHIC STUDIES ON TWO BIOISOSTERIC ANALOGUES, N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE AND N-TRIFLUOROACETYL-BETA-D-GLUCOPYRANOSYLAMINE, POTENT INHIBITORS OF MUSCLE GLYCOGEN PHOSPHORYLASE |
1XC7 | A:486-812; A:12-485,A:813-836 | BINDING OF BETA-D-GLUCOPYRANOSYL BISMETHOXYPHOSPHORAMIDATE TO GLYCOGEN PHOSPHORYLASE B: KINETIC AND CRYSTALLOGRAPHIC STUDIES |
1XKX | A:486-812; A:12-485,A:813-836 | KINETIC AND CRYSTALLOGRAPHIC STUDIES ON 2-(BETA-D-GLUCOPYRANOSYL)-5-METHYL-1,3,4-OXADIAZOLE,-BENZOTHIAZOLE, AND-BENZIMIDAZOLE, INHIBITORS OF MUSCLE GLYCOGEN PHOSPHORYLASE B. EVIDENCE FOR A NEW BINDING SITE. |
1XL0 | A:486-812; A:12-485,A:813-836 | KINETIC AND CRYSTALLOGRAPHIC STUDIES ON 2-(BETA-D-GLUCOPYRANOSYL)-5-METHYL-1,3,4-OXADIAZOLE,-BENZOTHIAZOLE, AND-BENZIMIDAZOLE, INHIBITORS OF MUSCLE GLYCOGEN PHOSPHORYLASE B. EVIDENCE FOR A NEW BINDING SITE. |
1XL1 | A:486-812; A:12-485,A:813-836 | KINETIC AND CRYSTALLOGRAPHIC STUDIES ON 2-(BETA-D-GLUCOPYRANOSYL)-5-METHYL-1,3,4-OXADIAZOLE,-BENZOTHIAZOLE, AND-BENZIMIDAZOLE, INHIBITORS OF MUSCLE GLYCOGEN PHOSPHORYLASE B. EVIDENCE FOR A NEW BINDING SITE. |
1Z62 | A:486-812; A:12-485,A:813-836 | INDIRUBIN-3'-AMINOOXY-ACETATE INHIBITS GLYCOGEN PHOSPHORYLASE BY BINDING AT THE INHIBITOR AND THE ALLOSTERIC SITE. BROAD SPECIFICITIES OF THE TWO SITES |
1Z6P | A:486-812; A:10-485,A:813-832 | GLYCOGEN PHOSPHORYLASE AMP SITE INHIBITOR COMPLEX |
1Z6Q | A:486-812; A:10-485,A:813-832 | GLYCOGEN PHOSPHORYLASE WITH INHIBITOR IN THE AMP SITE |
2AMV | A:486-812; A:13-485,A:813-836 | THE STRUCTURE OF GLYCOGEN PHOSPHORYLASE B WITH AN ALKYL-DIHYDROPYRIDINE-DICARBOXYLIC ACID |
2F3P | A:486-812; A:12-485,A:813-836 | CRYSTAL STRUCTURE OF THE GLYCOGEN PHOSPHORYLASE B / N-(BETA-D-GLUCOPYRANOSYL)OXAMIC ACID COMPLEX |
2F3Q | A:486-812; A:12-485,A:813-836 | CRYSTAL STRUCTURE OF THE GLYCOGEN PHOSPHORYLASE B / METHYL-N-(BETA-D-GLUCOPYRANOSYL)OXAMATE COMPLEX |
2F3S | A:486-812; A:12-485,A:813-836 | CRYSTAL STRUCTURE OF THE GLYCOGEN PHOSPHORYLASE B / ETHYL-N-(BETA-D-GLUCOPYRANOSYL)OXAMATE COMPLEX |
2F3U | A:486-812; A:12-485,A:813-836 | CRYSTAL STRUCTURE OF THE GLYCOGEN PHOSPHORYLASE B / N-(BETA-D-GLUCOPYRANOSYL)-N'-CYCLOPROPYL OXALAMIDE COMPLEX |
2FET | A:486-812; A:12-485,A:813-836 | SYNTHESIS OF C-D-GLYCOPYRANOSYL-HYDROQUINONES AND-BENZOQUINONES. INHIBITION OF PTP1B. INHIBITION OF AND BINDING TO GLYCOGEN PHOSPHORYLASE IN THE CRYSTAL |
2FF5 | A:486-812; A:12-485,A:813-836 | SYNTHESIS OF C-D-GLYCOPYRANOSYL-HYDROQUINONES AND-BENZOQUINONES. INHIBITION OF PTP1B. INHIBITION OF AND BINDING TO GLYCOGEN PHOSPHORYLASE IN THE CRYSTAL |
2FFR | A:486-812; A:12-485,A:813-836 | CRYSTALLOGRAPHIC STUDIES ON N-AZIDO-BETA-D-GLUCOPYRANOSYLAMINE, AN INHIBITOR OF GLYCOGEN PHOSPHORYLASE: COMPARISON WITH N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE |
2G9Q | A:486-812; A:12-485,A:813-836 | THE CRYSTAL STRUCTURE OF THE GLYCOGEN PHOSPHORYLASE B- 1AB COMPLEX |
2G9R | A:486-812; A:12-485,A:813-836 | THE CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH (3R, 4R,5R)-5-HYDROXYMETHYL-1-(3-PHENYLPROPYL)-PIPERIDINE-3,4-DIOL |
2G9U | A:486-812; A:14-485,A:813-836 | THE CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE IN COMPLEX WITH (3R, 4R,5R)-5-HYDROXYMETHYL-1-(3-PHENYLPROPYL)-PIPERIDINE-3,4-DIOL AND PHOSPHATE |
2G9V | A:486-812; A:13-485,A:813-836 | THE CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE IN COMPLEX WITH (3R, 4R,5R)-5-HYDROXYMETHYLPIPERIDINE-3,4-DIOL AND PHOSPHATE |
2GJ4 | A:486-812; A:12-485,A:813-835 | STRUCTURE OF RABBIT MUSCLE GLYCOGEN PHOSPHORYLASE IN COMPLEX WITH LIGAND |
2GM9 | A:486-812; A:12-485,A:813-836 | STRUCTURE OF RABBIT MUSCLE GLYCOGEN PHOSPHORYLASE IN COMPLEX WITH THIENOPYRROLE |
2GPA | A:486-812; A:10-485,A:813-836 | ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL ANTIDIABETIC DRUG |
2GPB | A:486-812; A:12-485,A:813-836 | COMPARISON OF THE BINDING OF GLUCOSE AND GLUCOSE-1-PHOSPHATE DERIVATIVES TO T-STATE GLYCOGEN PHOSPHORYLASE B |
2GPN | A:486-812; A:13-485,A:813-833 | 100 K STRUCTURE OF GLYCOGEN PHOSPHORYLASE AT 2.0 ANGSTROMS RESOLUTION |
2IEG | A:486-812; B:486-812; A:12-485,A:813-833; B:10-485,B:813-833 | CRYSTAL STRUCTURE OF RABBIT MUSCLE GLYCOGEN PHOSPHORYLASE IN COMPLEX WITH 3,4-DIHYDRO-2-QUINOLONE |
2IEI | A:486-812; A:12-485,A:813-831; B:12-485,B:813-833; B:486-812 | CRYSTAL STRUCTURE OF RABBIT MUSCLE GLYCOGEN PHOSPHORYLASE IN COMPLEX WITH 3,4-DIHYDRO-2-QUINOLONE |
2OFF | A:486-812; A:12-485,A:813-836 | THE CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH A POTENT ALLOSTERIC INHIBITOR |
2PRI | A:486-812; A:13-485,A:813-836 | BINDING OF 2-DEOXY-GLUCOSE-6-PHOSPHATE TO GLYCOGEN PHOSPHORYLASE B |
2PRJ | A:486-812; A:13-485,A:813-836 | BINDING OF N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE TO GLYCOGEN PHOSPHORYLASE B |
2PYD | A:486-812; A:10-485,A:813-835 | THE CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE IN COMPLEX WITH GLUCOSE AT 100 K |
2PYI | A:486-812; A:10-485,A:813-835 | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE IN COMPLEX WITH GLUCOSYL TRIAZOLEACETAMIDE |
2QN1 | A:486-812; A:12-485,A:813-836 | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH ASIATIC ACID |
2QN2 | A:486-812; A:12-485,A:813-836 | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH MASLINIC ACID |
2QN3 | A:486-812; A:12-485,A:813-836 | GLYCOGEN PHOSPHORYLASE IN COMPLEX WITH N-4-CHLOROBENZOYL-N-BETA-D-GLUCOPYRANOSYL UREA |
2QN8 | A:486-812; A:12-485,A:813-833 | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH N-4-NITROBENZOYL-N'-BETA-D-GLUCOPYRANOSYL UREA |
2QRG | A:486-812; A:12-485,A:813-836 | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH (1R)-3'-(4-METHOXYPHENYL)-SPIRO[1,5-ANHYDRO-D-GLUCITOL-1,5'-ISOXAZOLINE] |
2QRH | A:486-812; A:12-485,A:813-836 | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH (1R)-3'-PHENYLSPIRO[1,5-ANHYDRO-D-GLUCITOL-1,5'-ISOXAZOLINE] |
2QRM | A:486-812; A:12-485,A:813-836 | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH (1R)-3'-(4-NITROPHENYL)-SPIRO[1,5-ANHYDRO-D-GLUCITOL-1,5'-ISOXAZOLINE] |
2QRP | A:486-812; A:10-485,A:813-835 | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH (1R)-3'-(2-NAPHTHYL)-SPIRO[1,5-ANHYDRO-D-GLUCITOL-1,5'-ISOXAZOLINE] |
2QRQ | A:486-812; A:10-485,A:813-835 | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH (1R)-3'-(4-METHYLPHENYL)-SPIRO[1,5-ANHYDRO-D-GLUCITOL-1,5'-ISOXAZOLINE] |
2SKC | A:486-812; A:13-485,A:813-836 | PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH FLUOROPHOSPHATE, GLUCOSE AND INOSINE-5'-MONOPHOSPHATE |
2SKD | A:486-812; A:13-485,A:813-836 | PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH PHOSPHATE, GLUCOSE AND INOSINE-5'-MONOPHOSPHATE |
2SKE | A:486-812; A:13-485,A:813-836 | PYRIDOXAL PHOSPHORYLASE B IN COMPLEX WITH PHOSPHITE, GLUCOSE AND INOSINE-5'-MONOPHOSPHATE |
3AMV | A:486-812; A:10-485,A:813-833 | ALLOSTERIC INHIBITION OF GLYCOGEN PHOSPHORYLASE A BY A POTENTIAL ANTIDIABETIC DRUG |
3BCR | A:486-812; A:12-485,A:813-836 | GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH AZT |
3BCS | A:486-812; A:12-485,A:813-836 | GLYCOGEN PHOSPHORYLASE COMPLEX WITH 1(-D-GLUCOPYRANOSYL) URACIL |
3BCU | A:486-812; A:12-485,A:813-836 | GLUCOGEN PHOSPHORYLASE COMPLEX WITH THYMIDINE |
3BD6 | A:486-812; A:12-485,A:813-836 | GLYCOGEN PHOSPHORYLASE COMPLEX WITH 1(-D-RIBOFURANOSYL) CYANURIC ACID |
3BD7 | A:486-812; A:12-485,A:813-836 | GLYCOGEN PHOSPHORYLASE COMPLEX WITH 1(-D-GLUCOPYRANOSYL) THYMINE |
3BD8 | A:486-812; A:12-485,A:813-836 | GLUCOGEN PHOSPHORYLASE COMPLEX WITH 1(-D-GLUCOPYRANOSYL) CYTOSINE |
3BDA | A:486-812; A:12-485,A:813-836 | GLYCOGEN PHOSPHORYLASE COMPLEX WITH 1(-D-GLUCOPYRANOSYL) CYANURIC ACID |
3CUT | A:486-812; A:12-485,A:813-836 | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH N-(-D-GLUCOPYRANOSYL)-N'-(2-NAPHTHYL)OXAMIDE |
3CUU | A:486-812; A:12-485,A:813-836 | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH N-(-D-GLUCOPYRANOSYL)-N'-(2-NAPHTHYL)OXAMIDES |
3CUV | A:486-812; A:9-485,A:813-835 | TRACKING STRUCTURE ACTIVITY RELATIONSHIPS OF GLYCOGEN PHOSPHORYLASE INHIBITORS: SYNTHESIS, KINETIC AND CRYSTALLOGRAPHIC EVALUATION OF ANALOGUES OF N-(-D-GLUCOPYRANOSYL)-N'-OXAMIDES |
3CUW | A:486-812; A:12-485,A:813-836 | CRYSTAL STRUCTURE OF GLYCOGEN PHOSPHORYLASE B IN COMPLEX WITH N-(-D-GLUCOPYRANOSYL)-N'-(2-NAPHTHYL)OXAMIDES |
3G2H | A:486-812; A:12-485,A:813-836 | CRYSTAL STRUCTURE OF 1-(BETA-D-GLUCOPYRANOSYL)-4-SUBSTITUTED-1,2,3-TRIAZOLES IN COMPLEX WITH GLYCOGEN PHOSPHORYLASE |
3G2I | A:486-812; A:12-485,A:813-836 | CRYSTAL STRUCTURE OF 1-(BETA-D-GLUCOPYRANOSYL)-4-SUBSTITUTED-1,2,3-TRIAZOLE |
3G2J | A:486-812; A:12-485,A:813-836 | CRYSTAL STRUCTURE OF 1-(BETA-D-GLUCOPYRANOSYL)-4-SUBSTITUTED-1,2,3-TRIAZOLES IN COMPLEX WITH GLYCOGEN PHOSPHORYLASE |
3G2K | A:486-812; A:12-485,A:813-836 | CRYSTAL STRUCTURE OF 1-(BETA-D-GLUCOPYRANOSYL)-4-SUBSTITUTED-1,2,3-TRIAZOLE |
3G2L | A:486-812; A:12-485,A:813-836 | CRYSTAL STRUCTURE OF 1-(BETA-D-GLUCOPYRANOSYL)-4-SUBSTITUTED-1,2,3-TRIAZOLES IN COMPLEX WITH GLYCOGEN PHOSPHORYLASE |
3G2N | A:486-812; A:12-485,A:813-836 | CRYSTAL STRUCTURE OF N-ACYLGLUCOSYLAMINE WITH GLYCOGEN PHOSPHORYLASE |
3GPB | A:486-812; A:10-485,A:813-836 | COMPARISON OF THE BINDING OF GLUCOSE AND GLUCOSE-1-PHOSPHATE DERIVATIVES TO T-STATE GLYCOGEN PHOSPHORYLASE B |
4GPB | A:486-812; A:10-485,A:813-836 | COMPARISON OF THE BINDING OF GLUCOSE AND GLUCOSE-1-PHOSPHATE DERIVATIVES TO T-STATE GLYCOGEN PHOSPHORYLASE B |
5GPB | A:486-812; A:10-485,A:813-836 | COMPARISON OF THE BINDING OF GLUCOSE AND GLUCOSE-1-PHOSPHATE DERIVATIVES TO T-STATE GLYCOGEN PHOSPHORYLASE B |
7GPB | A:486-812; A:10-485,A:813-836; B:10-485,B:813-836; C:10-485,C:813-836; D:10-485,D:813-836; B:486-812; C:486-812; D:486-812 | STRUCTURAL MECHANISM FOR GLYCOGEN PHOSPHORYLASE CONTROL BY PHOSPHORYLATION AND AMP |
8GPB | A:486-812; A:11-485,A:813-836 | STRUCTURAL MECHANISM FOR GLYCOGEN PHOSPHORYLASE CONTROL BY PHOSPHORYLATION AND AMP |
9GPB | A:486-812; A:10-485,A:813-834; B:10-485,B:813-834; C:10-485,C:813-835; D:10-485,D:813-835; B:486-812; C:486-812; D:486-812 | THE ALLOSTERIC TRANSITION OF GLYCOGEN PHOSPHORYLASE |